BCRXBIOCRYST PHARMACEUTICALS INC

CUSIP: 09058V103

Guru Owners

$1.8M

Total Value Held

235,572

Total Shares

Investor	Fund	Shares	Value▼	% of Portfolio	Rpt Price	Period
Ray Dalio	Bridgewater Associates	235572	$1.8M	0.01%	$7.80	Q4 2025

Ray Dalio

$1.8M

0.01%

📊 Fundamentals

Market Cap$2.3B

P/E Ratio7.4x

Below market avg

Forward P/E11.2x

P/FCF8.8x

EPS (TTM)$1.21

Revenue (TTM)$874.8M

Profit Margin30.16%

Beta0.69

52-Week Range

$6.00

$11.31

Current: $9.01

Data from Yahoo Finance · refreshed every 4 hours

💡 Trades at 7.4x trailing earnings → 11.2x forward · 30.2% profit margin

📊 Holdings Over Time

How superinvestor ownership has changed across quarters

Quarter-by-Quarter Activity

Q4 '251 owners · $1.8M

REDUCEDRay Dalio$1.8M

Q3 '251 owners · $3.1M

No changes

💰 DCF Calculator

DCF model · 10-yr forecast

Estimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.

📊 Adjust the assumptions below to calculate an estimated fair value

Projection Period

Revenue Growth Rate

13%analyst est. 12.6%

0%100%

Growth Decay Rate

15%

0% (no decay)50% (fast decay)

Terminal Growth Rate

3.0%

0%5%

FCF Margin

29.3%current: 29.3%

1%50%

Discount Rate (WACC)

8.0%typical: 8% large caps · 10% growth

5%20%

Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data

🏛️ Congressional Trades

BCRX: Held by 1 superinvestors · 1 congress member trade

BUYGil CisnerosD

$1,001 - $15,0002025-11-13